Biochemical and Neuroimaging Studies in Subjective Cognitive Decline: Progress and Perspectives.

In conclusion, there is promising evidence indicating that clinicians should be able to differentiate pre-AD SCD based on the presence of pathophysiological biomarkers in cerebrospinal fluid (CSF) and neuroimaging. However, this neuroimaging approach is still at an immature stage without an established rubric of standards. A substantial amount of work remains in terms of replicating recent findings and validating the clinical utility of identifying SCD. PMID: 25864576 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25864576?dopt=Abstract

Source: CNS Neuroscience and Therapeutics - April 13, 2015 Category: Neuroscience Authors: Sun Y, Yang FC, Lin CP, Han Y Tags: CNS Neurosci Ther Source Type: research